Literature DB >> 24435850

Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study.

Viktória Kovacs1, Balazs Gasz, Borbala Balatonyi, Luca Jaromi, Peter Kisfali, Balazs Borsiczky, Gabor Jancso, Nandor Marczin, Sandor Szabados, Bela Melegh, Alotti Nasri, Elisabeth Roth.   

Abstract

In the present study we explored glutathione S-transferase (GST) polymorphisms in selected patients who experienced accelerated myocardial injury following open heart surgery and compared these to a control group of patients without postoperative complications. 758 Patients were enrolled from which 132 patients were selected to genotype analysis according to exclusion criteria. Patients were divided into the following groups: Group I: control patients (n = 78) without and Group II.: study patients (n = 54) with evidence of perioperative myocardial infarction. Genotyping for GSTP1 A (Ile105Ile/Ala113Ala), B (Ile105Val/Ala113Ala) and C (Ile105Val/Ala113Val) alleles was performed by using real-time-PCR. The heterozygous AC allele was nearly three times elevated (18.5 vs. 7.7 %) in the patients who suffered postoperative myocardial infarction compared to controls. Contrary, we found allele frequency of 14.1 % for homozygous BB allele in the control group whereas no such allele combination was present in the study group. These preliminary results may suggest the protective role for the B and C alleles during myocardial oxidative stress whereas the A allele may represent predisposing risk for cellular injury in patients undergoing cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24435850     DOI: 10.1007/s11010-013-1929-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran.

Authors:  Hamid Nomani; Hadi Mozafari; Shahrokh Mohamadzadeh Ghobadloo; Zohreh Rahimi; Asad Vaisi Raygani; Mehr Ali Rahimi; Asghar Fadaei Haghi; Ali Asghar Keshavarz
Journal:  Mol Cell Biochem       Date:  2011-04-16       Impact factor: 3.396

Review 2.  The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations.

Authors:  R I Hall; M S Smith; G Rocker
Journal:  Anesth Analg       Date:  1997-10       Impact factor: 5.108

3.  Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi.

Authors:  C J Henderson; C R Wolf; N Kitteringham; H Powell; D Otto; B K Park
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  Effect of the E-selectin gene polymorphism (S149R) on platelet activation and adverse events after coronary artery surgery.

Authors:  Ewa Stępień; Sylwia Krawczyk; Bogusław Kapelak; Robert Sobczyński; Jarosław Stoliński; Ewa Wypasek; Anetta Undas; Jerzy Sadowski
Journal:  Arch Med Res       Date:  2011-08-07       Impact factor: 2.235

Review 5.  Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.

Authors:  J D Hayes; L I McLellan
Journal:  Free Radic Res       Date:  1999-10

6.  Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.

Authors:  Amanda A Fox; Charles D Collard; Stanton K Shernan; Christine E Seidman; Jonathan G Seidman; Kuang-Yu Liu; Jochen D Muehlschlegel; Tjorvi E Perry; Sary F Aranki; Christoph Lange; Daniel S Herman; Thomas Meitinger; Peter Lichtner; Simon C Body
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

7.  Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery.

Authors:  Henry Völzke; Julia Engel; Volker Kleine; Christian Schwahn; Johannes B Dahm; Lothar Eckel; Rainer Rettig
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

Review 8.  Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis.

Authors:  L Nalysnyk; K Fahrbach; M W Reynolds; S Z Zhao; S Ross
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

9.  Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting.

Authors:  Ewa Wypasek; Ewa Stepien; Malgorzata Kot; Dariusz Plicner; Boguslaw Kapelak; Jerzy Sadowski; Anetta Undas
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

10.  Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.

Authors:  Sandra Eifert; Astrid Rasch; Andres Beiras-Fernandez; Georg Nollert; Bruno Reichart; Peter Lohse
Journal:  J Cardiothorac Surg       Date:  2009-08-19       Impact factor: 1.637

View more
  2 in total

1.  Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets.

Authors:  Thong H Cao; Donald J L Jones; Adriaan A Voors; Paulene A Quinn; Jatinderpal K Sandhu; Daniel C S Chan; Helen M Parry; Mohapradeep Mohan; Ify R Mordi; Iziah E Sama; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos Filippatos; Hans L Hillege; Marco Metra; Piotr Ponikowski; Nilesh J Samani; Dirk J Van Veldhuisen; Faiez Zannad; Chim C Lang; Leong L Ng
Journal:  Eur J Heart Fail       Date:  2019-11-06       Impact factor: 15.534

2.  Association of GSTP1 Ile105Val polymorphism with the risk of coronary heart disease: An updated meta-analysis.

Authors:  Yadong Song; Xiaoli Liu; Cheng Luo; Liangkai Chen; Lin Gong; Hanbin Yu; Bin Wang; Ernan Liu; Huiqiong Xu; Jiansheng Liang
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.